Literature DB >> 28938953

Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Ségolène Aymé1, Detlef Bockenhauer2, Simon Day3, Olivier Devuyst4, Lisa M Guay-Woodford5, Julie R Ingelfinger6, Jon B Klein7, Nine V A M Knoers8, Ronald D Perrone9, Julia Roberts10, Franz Schaefer11, Vicente E Torres12, Michael Cheung13, David C Wheeler14, Wolfgang C Winkelmayer15.   

Abstract

Rare kidney diseases encompass at least 150 different conditions, most of which are inherited. Although individual rare kidney diseases raise specific issues, as a group these rare diseases can have overlapping challenges in diagnosis and treatment. These challenges include small numbers of affected patients, unidentified causes of disease, lack of biomarkers for monitoring disease progression, and need for complex care. To address common clinical and patient issues among rare kidney diseases, the KDIGO Controversies Conference entitled, Common Elements in Rare Kidney Diseases, brought together a panel of multidisciplinary clinical providers and patient advocates to address five central issues for rare kidney diseases. These issues encompassed diagnostic challenges, management of kidney functional decline and progression of chronic kidney disease, challenges in clinical study design, translation of advances in research to clinical care, and provision of practical and integrated patient support. Thus, by a process of consensus, guidance for addressing these challenges was developed and is presented here.
Copyright © 2017 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic kidney disease progression; clinical trials; diagnostics; genetic kidney diseases; practical and integrated patient support; translational care

Mesh:

Substances:

Year:  2017        PMID: 28938953      PMCID: PMC6685068          DOI: 10.1016/j.kint.2017.06.018

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

Review 1.  Genomic medicine for kidney disease.

Authors:  Emily E Groopman; Hila Milo Rasouly; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2018-01-08       Impact factor: 28.314

2.  Moving the Science of Patient-Reported Outcome Measures Forward: Measuring Fatigue in Hemodialysis Patients.

Authors:  Sarah J Ramer; Jennifer S Scherer
Journal:  Clin J Am Soc Nephrol       Date:  2020-10-22       Impact factor: 8.237

3.  Diagnostic Utility of Exome Sequencing for Kidney Disease.

Authors:  Emily E Groopman; Maddalena Marasa; Sophia Cameron-Christie; Slavé Petrovski; Vimla S Aggarwal; Hila Milo-Rasouly; Yifu Li; Junying Zhang; Jordan Nestor; Priya Krithivasan; Wan Yee Lam; Adele Mitrotti; Stacy Piva; Byum H Kil; Debanjana Chatterjee; Rachel Reingold; Drew Bradbury; Michael DiVecchia; Holly Snyder; Xueru Mu; Karla Mehl; Olivia Balderes; David A Fasel; Chunhua Weng; Jai Radhakrishnan; Pietro Canetta; Gerald B Appel; Andrew S Bomback; Wooin Ahn; Natalie S Uy; Shumyle Alam; David J Cohen; Russell J Crew; Geoffrey K Dube; Maya K Rao; Sitharthan Kamalakaran; Brett Copeland; Zhong Ren; Joshua Bridgers; Colin D Malone; Caroline M Mebane; Neha Dagaonkar; Bengt C Fellström; Carolina Haefliger; Sumit Mohan; Simone Sanna-Cherchi; Krzysztof Kiryluk; Jan Fleckner; Ruth March; Adam Platt; David B Goldstein; Ali G Gharavi
Journal:  N Engl J Med       Date:  2018-12-26       Impact factor: 176.079

4.  Use of a Titanium Cage and Intramedullary Nails to Treat Distal Femoral Fracture Nonunion in a Patient with Renal Osteopathy: A Case Report.

Authors:  Hongyu Jin; Maoqi Xiong; Hui Zhou; Man Zhang; Xiao He; Dan Pu
Journal:  Am J Case Rep       Date:  2020-07-29

5.  Patient and clinician opinions of patient reported outcome measures (PROMs) in the management of patients with rare diseases: a qualitative study.

Authors:  Olalekan Lee Aiyegbusi; Fatima Isa; Derek Kyte; Tanya Pankhurst; Larissa Kerecuk; James Ferguson; Graham Lipkin; Melanie Calvert
Journal:  Health Qual Life Outcomes       Date:  2020-06-10       Impact factor: 3.186

Review 6.  Diagnostic Yield of Next-Generation Sequencing in Patients With Chronic Kidney Disease of Unknown Etiology.

Authors:  Amber de Haan; Mark Eijgelsheim; Liffert Vogt; Nine V A M Knoers; Martin H de Borst
Journal:  Front Genet       Date:  2019-12-13       Impact factor: 4.599

7.  Clinical outcomes and temporal trends of immunological and non-immunological rare diseases in adult kidney transplant.

Authors:  Ester Gallo; Silvia Mingozzi; Alberto Mella; Fabrizio Fop; Roberto Presta; Manuel Burdese; Elena Boaglio; Maria Cristina Torazza; Roberta Giraudi; Gianluca Leonardi; Antonio Lavacca; Paolo Gontero; Omidreza Sedigh; Andrea Bosio; Aldo Verri; Caterina Dolla; Luigi Biancone
Journal:  BMC Nephrol       Date:  2021-11-17       Impact factor: 2.388

Review 8.  A practical approach to the genomics of kidney disorders.

Authors:  Eleanor Hay; Thomas Cullup; Angela Barnicoat
Journal:  Pediatr Nephrol       Date:  2021-03-06       Impact factor: 3.714

9.  Pilot Study of Return of Genetic Results to Patients in Adult Nephrology.

Authors:  Jordan G Nestor; Maddalena Marasa; Hila Milo-Rasouly; Emily E Groopman; S Ali Husain; Sumit Mohan; Hilda Fernandez; Vimla S Aggarwal; Dina F Ahram; Natalie Vena; Kelsie Bogyo; Andrew S Bomback; Jai Radhakrishnan; Gerald B Appel; Wooin Ahn; David J Cohen; Pietro A Canetta; Geoffrey K Dube; Maya K Rao; Heather K Morris; Russell J Crew; Simone Sanna-Cherchi; Krzysztof Kiryluk; Ali G Gharavi
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-16       Impact factor: 10.614

10.  Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice.

Authors:  Nine Knoers; Corinne Antignac; Carsten Bergmann; Karin Dahan; Sabrina Giglio; Laurence Heidet; Beata S Lipska-Ziętkiewicz; Marina Noris; Giuseppe Remuzzi; Rosa Vargas-Poussou; Franz Schaefer
Journal:  Nephrol Dial Transplant       Date:  2022-01-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.